News Filter by: Industry Team Airport & AviationAutomotiveEnergyFood & Beverage Health CareHospitality & LeisureInsurance & ReinsuranceLife Sciences ManufacturingSportsTechnology Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial Institutions Private Equity & Venture CapitalReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyEPA RegulatoryExport Controls & National SecurityFDA RegulatoryFederal & State Energy RegulatoryFreight & Commuter Rail Government ProcurementImmigration, Nationality & Consular LawPolitical LawPublic PolicyStrategic Communications Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalCybersecurityElectronicsGreen Energy Technologies IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTechnology Transactions & OutsourcingTrademark, Copyright & Advertising Counseling International All InternationalChinaEurope JapanLatin America Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Law, Finance & Class Action Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & LitigationTrade Secret Noncompete Litigation Office BostonChicagoDetroitJacksonvilleLos AngelesMadison MiamiMilwaukeeNew YorkOrlandoSacramentoSan Diego San FranciscoSilicon ValleyTallahasseeTampaTokyoWashington, D.C. Topic Big DataCuba Foreign Corrupt Practices Act (FCPA)Health Care Reform Telemedicine In the News Press Releases Media Contact Jill Chanen Public Relations Manager jchanen foley.com 312.832.4745 1234next 15 August 2017 Foley Attorneys Recognized in The Best Lawyers in America 2018 List –Best Lawyers Foley announced today that 25 attorneys earned Best Lawyers® 2018 “Lawyer of the Year” recognition in their respective practice areas, receiving the top nod from Best Lawyers. 31 July 2017 Government & Public Policy Attorney Kyle Faget Joins Foley Kyle Faget has joined Foley & Lardner LLP’s Government & Public Policy Practice Group as special counsel in the Boston office. She has also joined the firm’s Health Care and Life Sciences Industry Teams. 14 July 2017 Rosen Comments on FDA User Fee Legislation –Modern Healthcare In Modern Healthcare’s article, “House Passes Bipartisan FDA User Fee Bill,” Partner David Rosen discussed the impact of new legislation passed in the House of Representatives that reauthorizes the FDA’s ability to collect user fees from drug and device makers. 05 June 2017 Foley Adds Intellectual Property Partner in New York Foley & Lardner LLP announced today that Karen Mangasarian has joined the firm’s Chemical, Biotechnology & Pharmaceutical Practice as a partner in the New York office. 01 June 2017 The Legal 500 United States Recognizes 19 Foley Practice Areas –The Legal 500 United States Foley has been recognized in 19 practice areas by The Legal 500 United States 2017, an analysis of law firms based on surveys and interviews of more than 250,000 corporate counsel. The firm maintained three top-tier recognitions and received 16 additional firm-wide recommendations. 01 November 2016 Foley Receives 27 National Tier 1 Practice Rankings by 2017 U.S. News – Best Lawyers –U.S. News – Best Lawyers® Foley announced today that it received 27 national Tier 1 rankings and 113 metropolitan Tier 1 rankings in the 2017 edition of U.S. News – Best Lawyers® “Best Law Firms.” 24 October 2016 Rosen Quoted on Obstacles to Generic EpiPen –Reuter’s Westlaw Partner David Rosen participated in a question and answer session with Reuter’s Westlaw, “Q&A: Foley & Lardner’s David Rosen on Obstacles to Generic EpiPen,” on October 24, 2106. 28 September 2016 Matthews Quoted on Mylan’s Potential DOJ Investigation –CNBC Partner James Matthews was quoted in a CNBC article, “Mylan ‘Incorrectly’ Classified EpiPens, Shortchanging Government: Regulators,” on September 28, 2016. 22 September 2016 Rosen Quoted on FDA Requirements for Drug Shelf Life –Modern Healthcare Partner David Rosen was quoted in a Modern Healthcare article, “Extending EpiPen Shelf Life Could be a Relief for Patients, Costly for Mylan,” on September 22, 2016. 15 June 2016 The Legal 500 United States Recognizes 19 Foley Practice Areas Foley has been recognized in 19 practice areas by The Legal 500 United States 2016, an analysis of law firms based on surveys and interviews of more than 250,000 corporate counsel. 1234next Search News Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared
15 August 2017 Foley Attorneys Recognized in The Best Lawyers in America 2018 List –Best Lawyers Foley announced today that 25 attorneys earned Best Lawyers® 2018 “Lawyer of the Year” recognition in their respective practice areas, receiving the top nod from Best Lawyers.
31 July 2017 Government & Public Policy Attorney Kyle Faget Joins Foley Kyle Faget has joined Foley & Lardner LLP’s Government & Public Policy Practice Group as special counsel in the Boston office. She has also joined the firm’s Health Care and Life Sciences Industry Teams.
14 July 2017 Rosen Comments on FDA User Fee Legislation –Modern Healthcare In Modern Healthcare’s article, “House Passes Bipartisan FDA User Fee Bill,” Partner David Rosen discussed the impact of new legislation passed in the House of Representatives that reauthorizes the FDA’s ability to collect user fees from drug and device makers.
05 June 2017 Foley Adds Intellectual Property Partner in New York Foley & Lardner LLP announced today that Karen Mangasarian has joined the firm’s Chemical, Biotechnology & Pharmaceutical Practice as a partner in the New York office.
01 June 2017 The Legal 500 United States Recognizes 19 Foley Practice Areas –The Legal 500 United States Foley has been recognized in 19 practice areas by The Legal 500 United States 2017, an analysis of law firms based on surveys and interviews of more than 250,000 corporate counsel. The firm maintained three top-tier recognitions and received 16 additional firm-wide recommendations.
01 November 2016 Foley Receives 27 National Tier 1 Practice Rankings by 2017 U.S. News – Best Lawyers –U.S. News – Best Lawyers® Foley announced today that it received 27 national Tier 1 rankings and 113 metropolitan Tier 1 rankings in the 2017 edition of U.S. News – Best Lawyers® “Best Law Firms.”
24 October 2016 Rosen Quoted on Obstacles to Generic EpiPen –Reuter’s Westlaw Partner David Rosen participated in a question and answer session with Reuter’s Westlaw, “Q&A: Foley & Lardner’s David Rosen on Obstacles to Generic EpiPen,” on October 24, 2106.
28 September 2016 Matthews Quoted on Mylan’s Potential DOJ Investigation –CNBC Partner James Matthews was quoted in a CNBC article, “Mylan ‘Incorrectly’ Classified EpiPens, Shortchanging Government: Regulators,” on September 28, 2016.
22 September 2016 Rosen Quoted on FDA Requirements for Drug Shelf Life –Modern Healthcare Partner David Rosen was quoted in a Modern Healthcare article, “Extending EpiPen Shelf Life Could be a Relief for Patients, Costly for Mylan,” on September 22, 2016.
15 June 2016 The Legal 500 United States Recognizes 19 Foley Practice Areas Foley has been recognized in 19 practice areas by The Legal 500 United States 2016, an analysis of law firms based on surveys and interviews of more than 250,000 corporate counsel.